Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

19.88
Delayed Data
As of May 22
 +0.57 / +2.95%
Today’s Change
9.38
Today|||52-Week Range
20.75
+65.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line180.4M-58.6M-108.4M-98.6M
 
 
 
 
 
Depreciation5.5M7.5M8.2M8.7M
 
 
 
 
 
Total Other Cash Flow17.6M17.0M16.7M15.8M
 
 
 
 
 
Funds From Operations203.4M-34.1M-83.6M-74.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-10.3M-43.1M3.3M-9.0M
 
 
 
 
 
Net Cash Flow - Operating Activities213.7M9.0M-86.8M-65.2M
 
 
 
 
 
 
InvestingIncrease In Investments-551.3M-515.5M-230.0M-111.8M
 
 
 
 
 
Decrease In Investments302.4M523.6M298.0M195.3M
 
 
 
 
 
Capital Expenditures-8.7M-15.5M-9.5M-8.4M
 
 
 
 
 
Net Cash Flow Investing-268.7M-7.4M58.6M75.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-1.7M0.000.000.00
 
 
Net Proceeds Stock Sale5.5M2.2M5.0M21.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing258.0K0.000.000.00
 
 
Net Cash Flow - Financing3.6M2.2M5.0M21.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash-51.4M3.7M-23.2M31.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account